Difference between revisions of "STBT5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
| [checked revision] | [checked revision] |
| Line 16: | Line 16: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|CHAPTER 2 (SOFT TISSUE TUMOURS) | |CHAPTER 2 (SOFT TISSUE TUMOURS) | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
---- | ---- | ||
| Line 54: | Line 39: | ||
|[[STBT5:Lipoma|Lipoma]] | |[[STBT5:Lipoma|Lipoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 70: | Line 50: | ||
|[[STBT5:Lipomatosis|Lipomatosis]] | |[[STBT5:Lipomatosis|Lipomatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 86: | Line 61: | ||
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]] | |[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 102: | Line 72: | ||
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]] | |[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 118: | Line 83: | ||
|[[STBT5:Angiolipoma_|Angiolipoma]] | |[[STBT5:Angiolipoma_|Angiolipoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 134: | Line 94: | ||
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]] | |[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 150: | Line 105: | ||
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]] | |[[STBT5:Chondroid_lipoma|Chondroid lipoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 166: | Line 116: | ||
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]] | |[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 182: | Line 127: | ||
|[[STBT5:Hibernoma|Hibernoma]] | |[[STBT5:Hibernoma|Hibernoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 198: | Line 138: | ||
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]] | |[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 214: | Line 149: | ||
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]] | |[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 230: | Line 160: | ||
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]] | |[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 246: | Line 171: | ||
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]] | |[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 262: | Line 182: | ||
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]] | |[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 278: | Line 193: | ||
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]] | |[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 294: | Line 204: | ||
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]] | |[[STBT5:Nodular_fasciitis|Nodular fasciitis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 310: | Line 215: | ||
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]] | |[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 326: | Line 226: | ||
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]] | |[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 342: | Line 237: | ||
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]] | |[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 358: | Line 248: | ||
|[[STBT5:Elastofibroma|Elastofibroma]] | |[[STBT5:Elastofibroma|Elastofibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 374: | Line 259: | ||
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]] | |[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 390: | Line 270: | ||
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]] | |[[STBT5:Fibromatosis_colli|Fibromatosis colli]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 406: | Line 281: | ||
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]] | |[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 422: | Line 292: | ||
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]] | |[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 438: | Line 303: | ||
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]] | |[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 454: | Line 314: | ||
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]] | |[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 470: | Line 325: | ||
|[[STBT5:Myofibroblastoma|Myofibroblastoma]] | |[[STBT5:Myofibroblastoma|Myofibroblastoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 486: | Line 336: | ||
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]] | |[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 502: | Line 347: | ||
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]] | |[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 518: | Line 358: | ||
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]] | |[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 534: | Line 369: | ||
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]] | |[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 550: | Line 380: | ||
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]] | |[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 566: | Line 391: | ||
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]] | |[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 582: | Line 402: | ||
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]] | |[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 598: | Line 413: | ||
|[[STBT5:Gardner_fibroma|Gardner fibroma]] | |[[STBT5:Gardner_fibroma|Gardner fibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 614: | Line 424: | ||
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]] | |[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 630: | Line 435: | ||
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]] | |[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 646: | Line 446: | ||
|[[STBT5:Lipofibromatosis|Lipofibromatosis]] | |[[STBT5:Lipofibromatosis|Lipofibromatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 662: | Line 457: | ||
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]] | |[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 678: | Line 468: | ||
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]] | |[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 702: | Line 487: | ||
| | | | ||
|Template added 2/21/2024 | |Template added 2/21/2024 | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] | |[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 726: | Line 501: | ||
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]] | |[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 742: | Line 512: | ||
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]] | |[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 758: | Line 523: | ||
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]] | |[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 774: | Line 534: | ||
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]] | |[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 790: | Line 545: | ||
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]] | |[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 806: | Line 556: | ||
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]] | |[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 822: | Line 567: | ||
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]] | |[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 838: | Line 578: | ||
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]] | |[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 854: | Line 589: | ||
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]] | |[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 870: | Line 600: | ||
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]] | |[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 886: | Line 611: | ||
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]] | |[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 902: | Line 622: | ||
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]] | |[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 918: | Line 633: | ||
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]] | |[[STBT5:Synovial_haemangioma|Synovial haemangioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 934: | Line 644: | ||
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]] | |[[STBT5:Intramuscular_angioma|Intramuscular angioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 950: | Line 655: | ||
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]] | |[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 966: | Line 666: | ||
|[[STBT5:Venous_haemangioma|Venous haemangioma]] | |[[STBT5:Venous_haemangioma|Venous haemangioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 982: | Line 677: | ||
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]] | |[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 998: | Line 688: | ||
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]] | |[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,014: | Line 699: | ||
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]] | |[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,030: | Line 710: | ||
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]] | |[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,046: | Line 721: | ||
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]] | |[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,062: | Line 732: | ||
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]] | |[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,078: | Line 743: | ||
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]] | |[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,094: | Line 754: | ||
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]] | |[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,110: | Line 765: | ||
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]] | |[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,126: | Line 776: | ||
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]] | |[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,142: | Line 787: | ||
|[[STBT5:Angiosarcoma|Angiosarcoma]] | |[[STBT5:Angiosarcoma|Angiosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,158: | Line 798: | ||
|[[STBT5:Glomus_tumour|Glomus tumour]] | |[[STBT5:Glomus_tumour|Glomus tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,174: | Line 809: | ||
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]] | |[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,190: | Line 820: | ||
|[[STBT5:Angioleiomyoma|Angioleiomyoma]] | |[[STBT5:Angioleiomyoma|Angioleiomyoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,206: | Line 831: | ||
|[[STBT5:Leiomyoma|Leiomyoma]] | |[[STBT5:Leiomyoma|Leiomyoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,222: | Line 842: | ||
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]] | |[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,238: | Line 853: | ||
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]] | |[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,254: | Line 864: | ||
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]] | |[[STBT5:Leiomyosarcoma|Leiomyosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,270: | Line 875: | ||
|[[STBT5:Rhabdomyoma|Rhabdomyoma]] | |[[STBT5:Rhabdomyoma|Rhabdomyoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,286: | Line 886: | ||
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]] | |[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,302: | Line 897: | ||
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]] | |[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,318: | Line 908: | ||
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]] | |[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,334: | Line 919: | ||
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]] | |[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,350: | Line 930: | ||
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]] | |[[STBT5:Ectomesenchymoma|Ectomesenchymoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,366: | Line 941: | ||
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]] | |[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,382: | Line 952: | ||
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]] | |[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,398: | Line 963: | ||
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]] | |[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,414: | Line 974: | ||
|[[STBT5:Schwannoma|Schwannoma]] | |[[STBT5:Schwannoma|Schwannoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,430: | Line 985: | ||
|[[STBT5:Neurofibroma|Neurofibroma]] | |[[STBT5:Neurofibroma|Neurofibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,446: | Line 996: | ||
|[[STBT5:Perineurioma|Perineurioma]] | |[[STBT5:Perineurioma|Perineurioma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,462: | Line 1,007: | ||
|[[STBT5:Granular_cell_tumour|Granular cell tumour]] | |[[STBT5:Granular_cell_tumour|Granular cell tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,478: | Line 1,018: | ||
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]] | |[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,494: | Line 1,029: | ||
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]] | |[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,510: | Line 1,040: | ||
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]] | |[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,526: | Line 1,051: | ||
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]] | |[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,542: | Line 1,062: | ||
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]] | |[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,558: | Line 1,073: | ||
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] | |[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,574: | Line 1,084: | ||
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]] | |[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,590: | Line 1,095: | ||
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]] | |[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,606: | Line 1,106: | ||
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]] | |[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,622: | Line 1,117: | ||
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]] | |[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,638: | Line 1,128: | ||
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]] | |[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,654: | Line 1,139: | ||
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]] | |[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,670: | Line 1,150: | ||
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]] | |[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,686: | Line 1,161: | ||
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]] | |[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,702: | Line 1,172: | ||
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]] | |[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,718: | Line 1,183: | ||
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]] | |[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,734: | Line 1,194: | ||
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]] | |[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,756: | Line 1,211: | ||
| | | | ||
|Alanna Church | |Alanna Church | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,766: | Line 1,216: | ||
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]] | |[[STBT5:Synovial_sarcoma|Synovial sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,782: | Line 1,227: | ||
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]] | |[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,798: | Line 1,238: | ||
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]] | |[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,814: | Line 1,249: | ||
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]] | |[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,830: | Line 1,260: | ||
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]] | |[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,846: | Line 1,271: | ||
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]] | |[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,862: | Line 1,282: | ||
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]] | |[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,878: | Line 1,293: | ||
|[[STBT5:PEComa|PEComa]] | |[[STBT5:PEComa|PEComa]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,894: | Line 1,304: | ||
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]] | |[[STBT5:Intimal_sarcoma|Intimal sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,910: | Line 1,315: | ||
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]] | |[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,925: | Line 1,325: | ||
|- | |- | ||
|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE) | |CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE) | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
---- | ---- | ||
| Line 1,964: | Line 1,354: | ||
| | | | ||
|2021 template added | |2021 template added | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]] | |[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 1,988: | Line 1,368: | ||
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] | |[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,004: | Line 1,379: | ||
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]] | |[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,019: | Line 1,389: | ||
|- | |- | ||
|CHAPTER 4 (BONE TUMOURS) | |CHAPTER 4 (BONE TUMOURS) | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
---- | ---- | ||
| Line 2,050: | Line 1,410: | ||
|[[STBT5:Subungual_exostosis|Subungual exostosis]] | |[[STBT5:Subungual_exostosis|Subungual exostosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,066: | Line 1,421: | ||
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]] | |[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,082: | Line 1,432: | ||
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]] | |[[STBT5:Periosteal_chondroma|Periosteal chondroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,098: | Line 1,443: | ||
|[[STBT5:Enchondroma|Enchondroma]] | |[[STBT5:Enchondroma|Enchondroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,114: | Line 1,454: | ||
|[[STBT5:Osteochondroma|Osteochondroma]] | |[[STBT5:Osteochondroma|Osteochondroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,130: | Line 1,465: | ||
|[[STBT5:Chondroblastoma|Chondroblastoma]] | |[[STBT5:Chondroblastoma|Chondroblastoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,146: | Line 1,476: | ||
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]] | |[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,162: | Line 1,487: | ||
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]] | |[[STBT5:Osteochondromyxoma|Osteochondromyxoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,178: | Line 1,498: | ||
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]] | |[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,194: | Line 1,509: | ||
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]] | |[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,210: | Line 1,520: | ||
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]] | |[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,226: | Line 1,531: | ||
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]] | |[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,242: | Line 1,542: | ||
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]] | |[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,258: | Line 1,553: | ||
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]] | |[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,274: | Line 1,564: | ||
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]] | |[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,290: | Line 1,575: | ||
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] | |[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,306: | Line 1,586: | ||
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]] | |[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,322: | Line 1,597: | ||
|[[STBT5:Osteoma|Osteoma]] | |[[STBT5:Osteoma|Osteoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,338: | Line 1,608: | ||
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]] | |[[STBT5:Osteoid_osteoma_|Osteoid osteoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,354: | Line 1,619: | ||
|[[STBT5:Osteoblastoma_|Osteoblastoma]] | |[[STBT5:Osteoblastoma_|Osteoblastoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,370: | Line 1,630: | ||
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]] | |[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,386: | Line 1,641: | ||
|[[STBT5:Osteosarcoma|Osteosarcoma]] | |[[STBT5:Osteosarcoma|Osteosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,402: | Line 1,652: | ||
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]] | |[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,418: | Line 1,663: | ||
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]] | |[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,434: | Line 1,674: | ||
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]] | |[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,450: | Line 1,685: | ||
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]] | |[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,466: | Line 1,696: | ||
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]] | |[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,482: | Line 1,707: | ||
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]] | |[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,498: | Line 1,718: | ||
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]] | |[[STBT5:Haemangioma_of_bone|Haemangioma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,514: | Line 1,729: | ||
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]] | |[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,530: | Line 1,740: | ||
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]] | |[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,546: | Line 1,751: | ||
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]] | |[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,562: | Line 1,762: | ||
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]] | |[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,578: | Line 1,773: | ||
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]] | |[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,594: | Line 1,784: | ||
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]] | |[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,610: | Line 1,795: | ||
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]] | |[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,626: | Line 1,806: | ||
|[[STBT5:Conventional_chordoma|Conventional chordoma]] | |[[STBT5:Conventional_chordoma|Conventional chordoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,642: | Line 1,817: | ||
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]] | |[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,658: | Line 1,828: | ||
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]] | |[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,674: | Line 1,839: | ||
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]] | |[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,690: | Line 1,850: | ||
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]] | |[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,706: | Line 1,861: | ||
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]] | |[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,722: | Line 1,872: | ||
|[[STBT5:Simple_bone_cyst|Simple bone cyst]] | |[[STBT5:Simple_bone_cyst|Simple bone cyst]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,738: | Line 1,883: | ||
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]] | |[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,754: | Line 1,894: | ||
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]] | |[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,770: | Line 1,905: | ||
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]] | |[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,786: | Line 1,916: | ||
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]] | |[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,802: | Line 1,927: | ||
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]] | |[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,818: | Line 1,938: | ||
|[[STBT5:Bone_metastases|Bone metastases]] | |[[STBT5:Bone_metastases|Bone metastases]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,834: | Line 1,949: | ||
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]] | |[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,850: | Line 1,960: | ||
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]] | |[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,866: | Line 1,971: | ||
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]] | |[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,882: | Line 1,982: | ||
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]] | |[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,898: | Line 1,993: | ||
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | |[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,913: | Line 2,003: | ||
|- | |- | ||
|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE) | |CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE) | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
---- | ---- | ||
| Line 2,944: | Line 2,024: | ||
|[[STBT5:Enchondromatosis|Enchondromatosis]] | |[[STBT5:Enchondromatosis|Enchondromatosis]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,960: | Line 2,035: | ||
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | |[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,976: | Line 2,046: | ||
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]] | |[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 2,992: | Line 2,057: | ||
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]] | |[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 3,008: | Line 2,068: | ||
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | |[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 3,024: | Line 2,079: | ||
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]] | |[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
| Line 3,040: | Line 2,090: | ||
|[[STBT5:Werner_syndrome|Werner syndrome]] | |[[STBT5:Werner_syndrome|Werner syndrome]] | ||
|Disease | |Disease | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
| | | | ||
Revision as of 11:38, 23 February 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.